Disposition of [¹⁴C]-LY3023414 Following Oral Administration in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2015
At a glance
- Drugs LY 3023414 (Primary)
- Indications Endometrial cancer; Non-small cell lung cancer; Prostate cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 20 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 Oct 2015 New trial record